Clinical Research Directory
Browse clinical research sites, groups, and studies.
GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Summary
Palliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor size, tumor location and tumor pathology. However, for many patients this treatment involves considerable toxicity, travel and time spent at the hospital. Spatially fractionated radiation (SFR) is an alternative technique that consists in delivering one single treatment, given through a grid containing holes. The present study is proposing to validate SFR as a safe and effective mean to palliate patients with symptomatic bulky tumors (more than 8 cm) or with tumors known to be resistant to radiation.
Official title: Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2015-01
Completion Date
2027-12
Last Updated
2026-05-12
Healthy Volunteers
No
Conditions
Interventions
spatially fractionated radiation therapy
A single dose of 15-20Gys of spatially fractionated radiation therapy
Locations (1)
Sir Mortimer Jewish General Hospital
Montreal, Quebec, Canada